Read More
Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
Novostia announces that it raised CHF 6.5 million from private investors to advance its disruptive aortic and mitral heart valve to clinical trials.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials"
Post a Comment